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Parasomniagic/hypnopompic hallucinations; HHHs), despite the fact that their prevalence in the general population is re-
ported to be higher than the prevalence of daytime hallucinations. We utilized data from an epidemiological
study to explore the prevalence of HHHs in various modalities. We also investigated phenomenological differ-Background: Few studies have investigated hallucinations that occur at the onset/offset of sleep (called hypnago-
ences between sleep-related (HHHs) and daytime hallucinations in the auditory modality. We hypothesized
that individuals with only HHHs would not differ from controls on a range of mental health and wellbeing mea-
sures, but that if they occur together with daytime hallucinations will pose a greater burden on the individual
experiencing them.We also hypothesize that HHHs are qualitatively different (i.e. less severe) from daytime hal-
lucinations.
Methods: This studyutilized data froma cross-sectional epidemiological study on the prevalence of hallucinations
in the Norwegian general population. The sample (n= 2533) was divided into a control group without halluci-
nations (n=2303), a group only experiencing sleep-related hallucinations (n=62), a group only experiencing
daytime hallucinations (n= 57), and a group experiencing both sleep-related as well as daytime hallucinations
(n = 111). Prevalence rates were calculated and groups were compared using analyses of variance and chi-
square tests where applicable.
Results: The prevalence for HHHs in the auditory domain was found to be 6.8%, whereas 12.3% reported multi-
modal HHHs, and 32.2% indicated out-of-body experiences at the onset/offset of sleep. Group comparisons of hal-
lucinations in the auditory modality showed that individuals that experienced only auditory HHHs scored
significantly (p<0.05) lower than thosewho also experienced daytime auditory hallucinations on a range of var-
iables including mental health, anxiety, childhood happiness, and wellbeing. In addition, individuals with only
auditory HHHs reported significantly (p < 0.05) less frequent hallucinations, less disturbing hallucinations,
more neutral (in terms of content) hallucinations, hallucinations with less influence over their behavior, and
less hallucination-related interference with social life compared to those individuals that experience daytime
hallucinations.We also found that purely auditory HHHs had a significantly higher age of first onset of hallucina-
tions than the purely daytime and the combined daytime and auditory HHHs groups (28.2 years>20.9 > 19.1).
Conclusions: Sleep-related hallucinations are common experiences in the general population, with the auditory
modality being the least common. They occur mostly in combination with daytime hallucinations. However,
some individuals (2.4%) experience only (auditory) sleep-related hallucinations and this group can be seen as
more closely related, on a range of health-related factors, to non-hallucinating individuals than individuals
who experience daytime hallucinations. Finally, there is a clear need for more research in this field, and ideas
for future studies are presented.
© 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).d Medical Psychology, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway.
. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Hallucinations are usually studied as a mental phenomenon that oc-
curs during wakefulness. Lesser studied, yet more common in the gen-
eral population, are hallucinations that occur in the borderline state
between falling asleep and being awake, often referred to as hypnagogic
(onset of sleep) and hypnopompic (upon awakening) hallucinations
(HHHs), respectively [1,2]. In the present study we report on HHHs in
the general population, which is an interesting phenomenon for a num-
ber of reasons. HHHs represent a particular type of hallucination, in a
particular situational context, in which the brain is in an altered state
of consciousness [see [3]]. Thus, studyingHHHsmay contribute to an in-
crease in our knowledge of hallucinations in general, and alsomore spe-
cifically increase our knowledge of hallucinations as a symptom in
mental disorders. Studying HHHs also represents a unique and rare op-
portunity to examine mental events that occur when the brain is in a
transition from wakefulness to sleep, and from sleep to wakefulness.
In a telephone survey of a representative sample of the general pop-
ulation (n=4972), Ohayon et al. [4] found that 37.0% of the sample re-
ported hypnagogic hallucinations and 12.5% reported hypnopompic
hallucinations (both multimodal), at least twice a week over the last
year. Jones et al. [2], using a different questionnaire (the Durham Hyp-
nagogic and Hypnopompic Hallucinations Questionnaire), found that
33.2% of their sample (college students) had experienced HHHs. As a
comparison, regarding daytime hallucinations, Laloyaux et al. [5]
(using the Launay-Slade Hallucination Scale (LSHS) [6]) reported a
7.0% prevalence rate of daytime hallucinations (across modalities) in
the Norwegian general population. Thus, HHHs seem to be amore com-
mon phenomenon than daytime hallucinations. Although HHHs can
occur independent from daytime hallucinations, they often seem to
co-occur as reported by Ohayon [7]. In this extended sample (n =
13,057), 24.1% of individuals with daytime hallucinations also reported
having hypnagogic hallucinations and 17% reported having hypnopom-
pic hallucinations.
As mentioned above, HHHs occur across sensory modalities. Waters
et al. [8] report that visual phenomena in some studies constitute up to
86% of HHHs and typically consist of kaleidoscopically changing visual
perceptions such as geometric patterns, shapes and light flashes. Fur-
thermore, somatic experiences, including bodily distortions, feelings of
weightlessness, flying or falling, and a sense of presence in the room,
occur in up to 44% of reported cases, while voices and other sounds
(phone, doorbell, music) appear to be less common (up to 34% of re-
ported cases) (see Waters et al. [8]). In order to allow to compare with
previous reports, we investigated prevalence rates for different sensory
modalities, i.e. auditory, out-of-body, and multimodal HHHs.
In addition to prevalence rates, we were also interested in under-
standing potential differences between individuals with only auditory
HHHs (aHHHs) compared to individuals with a) neither sleep-related
(aHHHs) nor daytime auditory verbal hallucinations (AVHs), (b) only
daytime AVHs, and (c) both aHHHs and daytime AVHs. This issue has
not been investigated previously. Following the continuum model of
psychosis [9], we expect hallucinations to be distributed among the
general population in various degrees of severity, from less severe, iso-
lated aHHHs to more severe hallucinations when co-occurring with
daytime hallucinations. Thus, it was hypothesized that individuals
with only aHHHs would not differ significantly from individuals with
neither aHHHs nor daytime AVHs. Further, we expected individuals
with only aHHHs to report less severe mental health issues and less se-
vere hallucination-characteristics (measured by e.g. frequency, valence,
level of disturbance), compared to the other hallucination groups, espe-
cially when compared with the group with combined aHHHs and day-
time AVHs. This is based on the assumption that isolated aHHHs (i.e.
without the presence of daytime AVHs) occur in a transitory state
from wakefulness to sleep, and from sleep to wakefulness, and as such
may be regarded as a common epiphenomenon of the complex2
interplay between cholinergic and aminergic neurochemical systems
rather than being part of a primary pathology.
2. Methods
2.1. Sample
This study utilized data from a cross-sectional epidemiological study
on the prevalence of AVHs in the Norwegian general population [see
[10]]. In order to avoid cultural and language differences that could
have confounded results, participants had to be able to speak and un-
derstand Norwegian, and be born, raised, and currently living in
Norway. In total, 8000 individuals aged 18 years and older were invited
to participate via a postal questionnaire. A total of 169 individuals could
not be reached and 11 individuals did not wish to participate in the
study, leaving 7820 individuals whowere contacted and did not explic-
itly decline to participate. Of these 7820 individuals, 2533 (32.4%) com-
pleted and returned the questionnaire, and therefore formed the final
study sample [see [10] for further details].
For the purpose of the present study, the original sample was di-
vided into four independent sub-groups depending on their answers
to three items of the Launay-Slade Hallucination Scale (LSHS), whereby
two items deal with daytime AVHs (items 4 and 8) and one item deals
with HHHs (modified item 11). The latter item was split into auditory
and multisensory modalities in order to differentiate between modali-
ties. The four independent sub-groups were as follows:
1) Participants who did not answer affirmatively (i.e. who responded,
“Certainly does not apply to me” or “Possibly does not apply to
me” or “Unsure”) to both daytime AVH and auditory HHH
(aHHH)-items. This sub-group is called the Control group and
consisted of 2303 participants.
2) Participants who answered affirmatively (i.e. who responded, “Possi-
bly applies to me” or “Certainly applies to me”) to the item about
aHHHs (modified item 11 of the LSHS: “Sometimes, right before I
fall asleep or wake up, I have had the experience of hearing a
voice, even though no one was there.”) but not affirmatively (“Cer-
tainly does not apply to me” or “Possibly does not apply to me” or
“Unsure”) to the items about daytime AVHs (item 4 of the LSHS:
“In the past I have had the experience of hearing a person's voice
and then found that there was no-one there” and/or item 8 of the
LSHS: “I often hear a voice speaking my thoughts aloud”). This sub-
group is called the aHHH group and consisted of 62 participants.
3) Participants who answered affirmatively (i.e. who responded, “Possi-
bly applies to me” or “Certainly applies to me”) to the items about
daytime AVHs (item 4 of the LSHS: “In the past I have had the expe-
rience of hearing a person's voice and then found that there was no-
one there” and/or item 8 of the LSHS: “I often hear a voice speaking
my thoughts aloud”) but not affirmatively (“Certainly does not apply
to me” or “Possibly does not apply to me” or “Unsure”) to the item
about aHHHs (modified item 11 of the LSHS: “Sometimes, right be-
fore I fall asleep or wake up, I have had the experience of hearing a
voice, even though no one was there.”). This sub-group is called
the AVH group and consisted of 57 participants.
4) Participants who answered affirmatively (i.e. who responded, “Possi-
bly applies to me” or “Certainly applies to me”) to the item about
aHHHs (modified item 11 of the LSHS: “Sometimes, right before I
fall asleep or wake up, I have had the experience of hearing a
voice, even though no onewas there.”) as well as affirmatively (“Pos-
sibly applies to me” or “Certainly applies to me”) to the questions
about daytime AVHs (item 4 of the LSHS: “In the past I have had
the experience of hearing a person's voice and then found that
there was no-one there” and/or item 8 of the LSHS: “I often hear a
voice speaking my thoughts aloud”). This sub-group is called the
AVH + aHHH group and consisted of 111 participants.
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Prevalence rates were calculated based on the following sleep-
related LSHS items:
1) aHHH (modified item 11 of the LSHS: “Sometimes, right before I fall
asleep orwake up, I have had the experience of hearing a voice, even
though no one was there.”)
2) out-of-body HHH (item 12 of the LSHS: “Sometimes, right before I
fall asleep or wake up, I have felt like I am floating or falling, or tem-
porarily leaving my body”)
3) multimodal HHH (modified item 11 of the LSHS: “Sometimes, right
before I fall asleep or wake up, I have had the experience of seeing
or feeling something that was not there, or felt like someone had
touched me, even though no one was there”)
Differences between the four independent sub-groups regarding
clinical features were explored based on questions regarding:
1) Physical health (“How is your physical health?”)
2) Mental health (“How is your mental health?”)
3) Hospital Anxiety and Depression Scale [HADS; [11]], which is a
fourteen-item questionnaire that measures the severity of anxiety
and depression. Each item is rated on a four-point response scale,
generating a total score ranging from 0 to 21.
4) Adverse life events (“Have you ever experienced a decisive adverse
event in your life such as death in the near family, accident, catastro-




Age (years) 50.2 (±16.2)











Registered partnership 0.2 (5)
Living status
Alone 16.9 (390)
With spouse/partner or other adult 40.3 (929)
Alone with child/children 3.1 (72)
With spouse/partner and child/children 33.7 (777)
With other adults and own children 0.6 (13)
Other 4.6 (105)
Highest educational level
Primary school 17.0 (391)
Vocational school 23.7 (546)
Secondary school 12.7 (293)
College 21.7 (499)
University (4 years or more) 24.5 (564)
Occupation
Employed 60.5 (1393)
Social welfare 24.5 (565)
Self-employed 5.2 (119)
Unemployed 1.5 (35)
Full-time domestic work 0.6 (15)
Student/military service 3.9 (90)
Other 3.3 (77)




aHHH: auditory hypnogogic and hypnopompic hallucinations; AVH: auditory verbal hallucina
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5) Considered contacting a health professional due to psycho-
logical issues (“Have you ever considered contacting a psy-
chologist, medical doctor, or similar, due to psychological
issues?”)
6) Intake of medication because of psychological issues (“Have you
used any medication for psychological problems?”)
7) Use of alcohol (frequency) (“How often do you drink alcohol?”)
8) General wellbeing (“How would you describe your general
condition?”)
9) Childhood happiness (“When thinking about your childhood/up-
bringing, you would describe it as…”)
Differences between the three independent hallucination sub-
groups were explored with regard to additional questions about
hallucination-characteristics:
1) Age of onset (“How oldwere you the first time you heard voices?”)
2) Frequency (“Approximately how often do you hear voices?”)
3) Valence (“The voices are experienced mainly as…”)
4) First-onset trigger (“What situation were you in when you first
started hearing voices”?)
5) Influence of hallucinations over one's behavior (“Have you allowed
the voices to influence your behavior?”)
6) Interference of hallucinations with social contacts (“Do the voices
interfere with your social interactions?”)
7) Level of disturbance of hallucinations (“I have been troubled by
hearing voices in my head”; item 9 of the LSHS)aHHH AVH AVH + aHHH
62 (SD) 57 (SD) 111 (SD)
49.7 (±16.1) 43.6 (13.8) 41.5 (16.3)
28.2 (±16.4) 20.9 (15.0) 19.1 (13.1)
% (N) % (N) % (N)
46.8 (29) 49.1 (28) 35.1 (39)
53.2 (33) 50.9 (29) 64.9 (72)
16.1 (10) 22.8 (13) 31.5 (35)
38.7 (24) 43.9 (25) 27.0 (30)
24.2 (15) 22.8 (13) 25.2 (28)
4.8 (3) 1.75 (1) 4.5 (5)
16.1 (10) 8.8 (5) 10.8 (12)
0 (0) 0 (0) 0 (0)
27.4 (17) 17.5 (10) 22.5 (25)
37.1 (23) 50.9 (29) 32.4 (36)
3.2 (2) 5.3 (3) 9.0 (10)
25.8 (16) 19.3 (11) 22.5 (25)
0 (0) 0 (0) 0 (0)
6.4 (4) 7.0 (4) 11.7 (13)
16.1 (10) 10.5 (6) 12.6 (14)
21.0 (13) 24.6 (14) 22.5 (25)
11.3 (7) 15.8 (9) 17.1 (19)
24.2 (15) 29.8 (17) 30.6 (34)
27.4 (17) 19.3 (11) 16.2 (18)
56.4 (35) 56.1 (32) 45.0 (50)
32.3 (20) 24.6 (14) 23.4 (26)
6.4 (4) 5.3 (3) 5.4 (6)
0 (0) 1.7 (1) 4.5 (5)
0 (0) 0 (0) 0.9 (1)
3.2 (2) 7.0 (4) 11.7 (13)
1.6 (1) 5.3 (3) 8.1 (9)
17.7 (11) 12.3 (7) 24.3 (27)
21.0 (13) 21.0 (12) 8.1 (9)
48.4 (30) 59.6 (34) 54.9 (61)
tions; H: health; LE: life events.
Table 2
Analyses of variance (ANOVAs) comparing the four sub-groups on general health and wellbeing variables.
Control aHHH AVH AVH + aHHH F (df) p
N = 2303 N = 62 N = 57 N = 111
Mean (SE) Mean (SE) Mean (SE) Mean (SE)
Physical H 2.99 (0.01)a 2.81 (0.09)a, b 2.95 (0.08)a, b 2.74 (0.08)b 6.08 (32522) <0.001
Mental H 3.29 (0.01)a 3.19 (0.11)a 3.04 (0.10)a, b 2.86 (0.09)b 14.29 (32532) <0.001
Anxiety 11.40 (0.1)a 12.25 (0.49)a, b 13.42 (0.55)b, c 14.46 (0.42)c 34.22 (32452) <0.001
Depression 10.03 (0.06)a 10.43 (0.46)a, b 11.05 (0.53)a, b 11.41 (0.40)b 9.10 (32485) <0.001
Adverse LE 1.42 (0.02)a 1.77 (0.12)b 1.84 (0.15)b 1.94 (0.12)b 13.67 (32503) <0.001
Alcohol 3.20 (0.03)a 3.39 (0.18)a 3.02 (0.17)a 3.00 (0.13)a 1.57 (32518) =0.206
Childhood 1.81 (0.02)a 1.95 (0.13)a 2.00 (0.13)a, b 2.39 (0.13)b 13.27 (32516) <0.001
Wellbeing 2.34 (0.02)a 2.50 (0.12)a 2.49 (0.14)a 2.94 (0.12)b 12.34 (32520) <0.001
aHHH: auditory hypnogogic and hypnopompic hallucinations; AVH: auditory verbal hallucinations; H: health; LE: life events.
Same superscript letter indicates no significant difference between groups; different superscript letter indicates significant difference between groups (p < 0.05).
Table 3
Chi-square analyses comparing the four sub-groups on general health variables.
Control aHHH AVH AVH + aHHH
N = 2303 N = 62 N = 57 N = 111
% (N) % (N) % (N) % (N)
Contact HP
Yes, now 5.9 (135)a 12.9 (8)a,b 10.5 (6)a,b 13.5 (15)b
Yes, before 19.6 (452)a 21.0 (13)a,b 36.8 (21)b 38.7 (43)b
No, never 29.1 (670)a 38.7 (24)a 33.3 (19)a 34.2 (38)a
N/A 44.6 (1027)a 27.4 (17)b 19.3 (11)b 12.6 (14)b
Medication
Yes, now 4.8 (111)a 9.7 (6)a,b 15.8 (9)b 11.7 (13)b
Yes, before 8.4 (194)a 12.9 (8)a,b 15.8 (9)a,b 16.2 (18)b
No, never 42.7 (983)a 51.6 (32)a 42.1 (24)a 54.1 (60)a
N/A 43.6 (1005)a 25.8 (16)b 26.3 (15)a,b 17.1 (19)b
aHHH: auditory hypnogogic and hypnopompic hallucinations; AVH: auditory verbal hal-
lucinations; HP: health professional.
Same superscript letter indicates no significant difference between groups; different su-
perscript letter indicates significant.
percentage-difference between groups (z > 1.96).
J.J. Bless, K. Hugdahl, B. Kråkvik et al. Comprehensive Psychiatry 108 (2021) 1522478) Contactwith a health professional because of hallucinations (“Have
you ever contacted a psychologist,medical doctor, or similar, due to
a problematic relationship with the voices?”)
10) Intake of medication because of hallucinations (“Have you used
medication for the voices you hear?”)
2.3. Statistical analysis
Differences between the groups were evaluated statistically using
one-way analyses of variance (ANOVAs), and significant effects were
followed up with post-hoc t-tests (p < 0.05; Bonferroni correction was
used to control for multiple comparisons). For testing relationships be-
tween groups on categorical variables, the chi-square testwas used. Dif-
ferences were regarded as significant for z > 1.96.
2.4. Ethical standards
The study was approved by the Regional Committee for Medical Re-
search Ethics in Central Norway (REC-Central) and all participants gave
their informed consent prior to their inclusion in the study.
3. Results
3.1. Prevalence of sleep-related hallucinations
In the sample of 2533 individuals who returned the questionnaire,
6.8% (n = 173) reported having experienced aHHHs, 12.3% (n = 312)
reported having had multimodal HHHs, and 32.2% (n= 816) indicated
that they had experienced out-of-body HHHs at least once in their life-
time. Of those individuals reporting aHHHs (n=173), 64.2% (n=111)
reported daytime AVHs as well. Individuals who reported aHHHs with-
out daytime AVHs, accounted for 2.4% (n = 62) of the overall sample,
while individuals who reported daytime AVHs without aHHHs com-
prised 2.2% (n = 57) of the overall sample (Table 1).
3.2. Differences between all four sub-groups with regard to general health
and wellbeing
The one-wayANOVAs showed significantmain effects for all general
health and wellbeing variables except for frequency of alcohol con-
sumption (see Table 2). Post-hoc analyses revealed that the Control
group reported better physical and mental health, lower anxiety and
depression scores, fewer adverse life events, a happier childhood, and
better general wellbeing, compared to the AVH + aHHH group. The
Control group also reported lower anxiety scores compared to the
aHHH group and fewer adverse life events compared to both the
aHHH group and the AVH group. In addition, the aHHH group reported
significantly better mental health, lower anxiety scores, a happier child-
hood, and better general wellbeing than the AVH + aHHH group.4
Finally, the AVH group reported better general wellbeing than the
AVH + aHHH group. See Table 2 for main effects and post-hoc effects.
Results from the chi-square tests (Table 3) showed that the Control
group included a significantly lower percentage of participants that had
considered or were considering contacting a health professional for
mental health problems, compared to the AVH + aHHH group. Also, a
higher percentage of control group participants rated this question as
not applicable compared to the other groups. With regard to medica-
tion, a significantly lower percentage of participants in the Control
group indicated that they had takenmedication formental health issues
compared to the AVH and AVH + aHHH groups. Also, a significantly
higher percentage of participants in the Control indicated that the ques-
tion was not applicable to them compared to the respective percentage
in the aHHH and AVH + aHHH groups.
3.3. Differences between the three hallucination sub-groups with regard to
AVH-related variables
A one-way ANOVAs showed significant main-effects of frequency of
AVHs, influence of AVHs over one's behavior, interference of AVHswith
social contacts, and level of disturbance of AVHs. Post-hoc tests revealed
that the aHHH group reported significantly less frequent hallucinations,
less disturbing hallucinations, hallucinations with less influence over
their behavior, and hallucinationswith less interferencewith social con-
tacts compared to the AVH group and the AVH + aHHH group (see
Table 4).
The chi-square results (see Table 5) showed that the aHHHgroup in-
cluded a significantly higher percentage of participants who reported
Table 4
Analyses of variance (ANOVAs) comparing the three AVH sub-groups on AVH-related variables.
aHHH AVH AVH + aHHH F (df) p
N = 62 N = 57 N = 111
Mean (SE) Mean (SE) Mean (SE)
Frequency 1.50 (0.11)a 2.36 (0.19)b 2.50 (0.13)b 13.12 (2202) p < 0.001
Influence 2.85 (0.06)a,b 2.48 (0.09)b 2.35 (0.07)b 11.72 (2199) p < 0.001
Interference 3.00 (0.00)a,b 2.78 (0.46)b 2.72 (0.54)b 7.11 (2199) p < 0.01
Disturbance 0.13 (0.07)a 0.81 (0.18)b 1.70 (0.16)c 26.96 (2222) p < 0.001
aHHH: auditory hypnogogic and hypnopompic hallucinations; AVH: auditory verbal hallucinations.
Same superscript letter indicates no significant difference between groups; different superscript letter indicates significant.
difference between groups (p < 0.05).
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therewas a significantly lower percentage of participantswho indicated
a first-onset trigger event in the aHHH group compared to the AVH +
aHHH group. With regard to AVH-related contact with health profes-
sionals, a significantly lower percentage of aHHH participants indicated
previous contact, and a significantly higher percentage of aHHH partic-
ipants rated the question as not applicable to them, compared to the
AVH+ aHHH group. Finally, a significantly higher percentage of partic-
ipants from the aHHH group rated the voice-related use of medication
question as not applicable to them.
3.4. Differences in age at first onset
A one-way ANOVA showed a significant main-effect of age at first
onset [F (3, 174) = 5.85, p < 0.01]. The post-hoc analysis revealed
that the aHHH group was significantly older at first onset of voices
(28.2 years) than both the AVH + aHHH group (19.1 years; p < 0.01)
and the AVH group (20.9 years; p < 0.05).Table 5
Chi-square analyses comparing the threeAVH sub-groups onAVHvalence,first-onset trig-
ger, contact with health professional regarding AVHs, and use of medication for AVHs.
aHHH AVH AVH + aHHH
N = 62 N = 57 N = 111
% (N) % (N) % (N)
AVH valence
Positive Yes 12.9 (8)a 17.5 (10)a 20.7 (23)a
No 87.1 (54)a 82.5 (47)a 79.3 (88)a
Negative Yes 4.8 (3)a 12.3 (7)a 9.0 (10)a
No 95.2 (59)a 87.7 (50)a 91.0 (101)a
Positive/Negative Yes 21.0 (13)a 24.6 (14)a 33.3 (37)a
No 79.0 (49)a 75.4 (43)a 66.7 (74)a
Neutral Yes 45.2 (28)a 40.4 (23)a,b 25.2 (28)b
No 54.8 (34)a 59.6 (34)a,b 74.8 (83)b
Other⁎ Yes 09.7 (6)a 5.3 (3)a 13.5 (15)a
No 90.3 (56)a 94.7 (54)a 86.5 (96)a
First-onset trigger Yes 35.5 (22)a 49.1 (28)a,b 55.0 (61)b
No 50.0 (31)a 42.1 (24)a,b 31.5 (35)b
Contact HP for AVH
Yes. now 0.0 (0)a 5.3 (3)a 2.7 (3)a
Yes. before 1.6 (1)a 10.5 (6)a.b 19.8 (22)b
No. never 54.8 (34)a 52.6 (30)a 52.3 (58)a
N/A 41.9 (26)a 31.6 (18)a,b 23.4 (26)b
Medication AVH
Yes 0.0 (0)a 8.8 (5)a 8.1 (9)a
No 54.8 (34)a 54.4 (31)a 64.0 (71)a
N/A 45.2 (28)a 36.8 (21)a,b 27.0 (30)b
aHHH: auditory hypnogogic and hypnopompic hallucinations; AVH: auditory verbal
hallucinations; HP: health professional.
Same superscript letter indicates no significant percentage-difference between groups;
different superscript letter indicates significant percentage-difference between groups
(z > 1.96).




In this general population sample, multimodal and out-of-body
HHHs were found to be more common than aHHHs (12.3% and 32.2%
compared to 6.8%). This is in linewith previous HHH-studies in the gen-
eral population [see [7,12]] and these findings are contrasting to find-
ings concerning daytime hallucinations in schizophrenia patients
where the auditory modality is dominant [13]. Also, aHHHs occurred
mostly (64.2%) in combination with daytime AVHs and vice versa
(66.1%), whereas isolated aHHHs (2.4%) and isolated daytime AVHs
(2.2%) were both seldom reported. In line with these findings, other
studies have found that hallucinations often occur inmore than onemo-
dality in individuals in the general population, while unimodal halluci-
nations are more infrequent [5,14].
As hypothesized, the aHHH group did not differ significantly from
the non-hallucinating control group for any of the general health pa-
rameters. On the other hand, the aHHH group showed better mental
health in several domains (e.g.mental health, childhood happiness, sub-
jective wellbeing, anxiety) than the AVH+ aHHH group. In fact, the re-
sults revealed a continuous increase of severity from the aHHH group to
the AVH group and further to theAVH+aHHHgroup. Thismay point to
a developmental process, with isolated aHHH as a potential starting
point for developing daytime hallucinations, for example, being trig-
gered by an adverse life event [cf. [15]]. However, a different explana-
tion is probably required when taking into account the results
regarding age of onset. Here, individuals appear to develop daytime
AVHs or combined AVH + aHHH at an earlier stage in life, suggesting
different symptom trajectories for only sleep-related (i.e. aHHH) versus
daytime AVHs or combined AVH + aHHH. It remains unknown, how-
ever, whether the occurrence of combined AVH + aHHH leads to
more mental health problems or vice versa. Nevertheless, while it was
known from previous studies that daytime AVHs were associated with
various mental health problems, the present study was able to show
that individualswith only aHHHwere not any different from individuals
without hallucinations (neither daytime nor sleep-related) on most
general health parameters except for adverse life events, which oc-
curred more often in the hallucination groups.
Furthermore, as hypothesized, the hallucination group with the sig-
nificantly least severe hallucination-characteristics (measured by e.g.
frequency, valence, level of disturbance) was the aHHH group. Similar
to the general health parameters, we found a continuous increase of se-
verity from the aHHHgroup to the AVH group and further to the AVH+
aHHH group with regard to hallucination-characteristics. This suggests
that when daytime and sleep-rated auditory hallucinations co-occur,
the hallucinations are the most debilitating. More research is needed
to shed light onwhen daytimeand sleep-related auditoryhallucinations
occur together, especially since they appear to have a different trajec-
tory than isolated aHHHs. Finally, it should be noted that all three hallu-
cination groups are non-clinical groups, which means they have not
received a diagnosis. At the same time, the results point towards the
AVH + aHHH group being the most prone to general health problems,
J.J. Bless, K. Hugdahl, B. Kråkvik et al. Comprehensive Psychiatry 108 (2021) 152247whereas the aHHH group did not differ significantly from the non-
hallucinating control group except for adverse life events, which were
more frequent in the aHHH group.
There are some limitations to the present study. Sleep disorders
were not assessed even though HHHs are common in narcolepsy
(ICSD-3; [16]), among persons with symptoms of insomnia and exces-
sive daytime sleepiness [4] andmay also occur as part of sleep paralysis
at sleep onset [17]. HHHs related to specific sleep disorders may repre-
sent qualitatively different experiences compared to HHHs not related
to sleep disorders. Another limitation is related to the fact that the
HHHs were not assessed separately (i.e. hypnagogic separate from hyp-
nopompic experiences) although there is some evidence that they rep-
resent qualitatively different phenomena [e.g. [4,18]].
There are few studies onHHHs in general, and thus several questions
remain to be addressed and they need to be rigorously examined in fu-
ture studies. For instance, does degree of sleep quality (as assessed by
using separate sleep measurements such as subjective questionnaire
data and objective sleep sensor data, cf. [19]) have an effect on sleep-
related hallucinations? Related to this, could interventions addressing
sleep problems affect how troublesome the hallucinations are? Which
neurobiological changes are occurring during the transition fromwake-
fulness to sleep and from sleep to wakefulness that may contribute to
producing HHHs? Do events during daytime play a role in the incidence
and content of HHHs (perhaps especially in hypnagogic hallucina-
tions)? Finally, are individual differences (e.g. suggestibility, personality
traits, absorption) involved in determining the incidence and/or nature
of HHHs?
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